We recently published a list of 10 AI News And Ratings on Wall Street’s Radar. In this article, we are going to take a look ...

Equities research analysts at Leerink Partnrs decreased their FY2024 EPS estimates for shares of Schrödinger in a research note issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

KeyBanc Capital Markets updated its outlook on Schrodinger (NASDAQ:SDGR), increasing the price target from $25.00 to $27.00 ...

KeyBanc raised the firm’s price target on Schrodinger (SDGR) to $27 from $25 and keeps an Overweight rating on the shares. The firm thinks a ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where Schrödinger, Inc. (NASDAQ:SDGR) stands against the other stocks ...

In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Schrodinger (SDGR – Research Report), with a price ...

Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...

The market has started to favor smaller companies in 2025, and stocks between $1 billion and $5 billion in market value are ...

During a speech at the White House on Tuesday, Ellison emphasized AI's ability to detect cancer early through blood tests and its crucial role in creating individualized vaccines rapidly. This ...

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.